Cargando…
Neutralization of the new coronavirus by extracting their spikes using engineered liposomes
The devastating COVID-19 pandemic motivates the development of safe and effective antivirals to reduce morbidity and mortality associated with infection. We developed nanoscale liposomes that are coated with the cell receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus...
Autores principales: | Zhang, Zhenjiang, King, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085972/ https://www.ncbi.nlm.nih.gov/pubmed/37054806 http://dx.doi.org/10.1016/j.nano.2023.102674 |
Ejemplares similares
-
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
por: Coleman, Christopher M., et al.
Publicado: (2014) -
Micelle-in-Liposomes for Sustained Delivery of Anticancer Agents That Promote Potent TRAIL-Induced Cancer Cell Apoptosis
por: Zhang, Zhenjiang, et al.
Publicado: (2020) -
Identification and characterization of a neutralizing-epitope-containing spike protein fragment in turkey coronavirus
por: Chen, Yi-Ning, et al.
Publicado: (2011) -
An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages
por: Satta, Sandro, et al.
Publicado: (2022) -
Engineering of Exosomes to Target Cancer Metastasis
por: Zhang, Zhenjiang, et al.
Publicado: (2019)